178 related articles for article (PubMed ID: 36631967)
1. Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality.
Wadström BN; Pedersen KM; Wulff AB; Nordestgaard BG
Eur Heart J; 2023 Apr; 44(16):1432-1445. PubMed ID: 36631967
[TBL] [Abstract][Full Text] [Related]
2. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.
Varbo A; Benn M; Tybjærg-Hansen A; Nordestgaard BG
Circulation; 2013 Sep; 128(12):1298-309. PubMed ID: 23926208
[TBL] [Abstract][Full Text] [Related]
3. Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study.
Wadström BN; Wulff AB; Pedersen KM; Jensen GB; Nordestgaard BG
Eur Heart J; 2022 Sep; 43(34):3258-3269. PubMed ID: 34661640
[TBL] [Abstract][Full Text] [Related]
4. Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease.
Castañer O; Pintó X; Subirana I; Amor AJ; Ros E; Hernáez Á; Martínez-González MÁ; Corella D; Salas-Salvadó J; Estruch R; Lapetra J; Gómez-Gracia E; Alonso-Gomez AM; Fiol M; Serra-Majem L; Corbella E; Benaiges D; Sorli JV; Ruiz-Canela M; Babió N; Sierra LT; Ortega E; Fitó M
J Am Coll Cardiol; 2020 Dec; 76(23):2712-2724. PubMed ID: 33272365
[TBL] [Abstract][Full Text] [Related]
5. Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study.
Kaltoft M; Langsted A; Nordestgaard BG
Eur Heart J; 2020 Jun; 41(24):2288-2299. PubMed ID: 32267934
[TBL] [Abstract][Full Text] [Related]
6. Remnant cholesterol as a causal risk factor for ischemic heart disease.
Varbo A; Benn M; Tybjærg-Hansen A; Jørgensen AB; Frikke-Schmidt R; Nordestgaard BG
J Am Coll Cardiol; 2013 Jan; 61(4):427-436. PubMed ID: 23265341
[TBL] [Abstract][Full Text] [Related]
7. Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment.
Varbo A; Benn M; Nordestgaard BG
Pharmacol Ther; 2014 Mar; 141(3):358-67. PubMed ID: 24287311
[TBL] [Abstract][Full Text] [Related]
8. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.
Nordestgaard BG
Circ Res; 2016 Feb; 118(4):547-63. PubMed ID: 26892957
[TBL] [Abstract][Full Text] [Related]
9. Remnant cholesterol, LDL cholesterol, and apoB absolute mass changes explain results of the PROMINENT trial.
Doi T; Langsted A; Nordestgaard BG
Atherosclerosis; 2024 Jun; 393():117556. PubMed ID: 38678642
[TBL] [Abstract][Full Text] [Related]
10. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.
Nordestgaard BG; Benn M; Schnohr P; Tybjaerg-Hansen A
JAMA; 2007 Jul; 298(3):299-308. PubMed ID: 17635890
[TBL] [Abstract][Full Text] [Related]
11. Elevated Remnant Cholesterol Reclassifies Risk of Ischemic Heart Disease and Myocardial Infarction.
Doi T; Langsted A; Nordestgaard BG
J Am Coll Cardiol; 2022 Jun; 79(24):2383-2397. PubMed ID: 35710189
[TBL] [Abstract][Full Text] [Related]
12. Contribution of remnant cholesterol to cardiovascular risk.
Langsted A; Madsen CM; Nordestgaard BG
J Intern Med; 2020 Jul; 288(1):116-127. PubMed ID: 32181933
[TBL] [Abstract][Full Text] [Related]
13. Increased Remnant Cholesterol Explains Part of Residual Risk of All-Cause Mortality in 5414 Patients with Ischemic Heart Disease.
Jepsen AM; Langsted A; Varbo A; Bang LE; Kamstrup PR; Nordestgaard BG
Clin Chem; 2016 Apr; 62(4):593-604. PubMed ID: 26888894
[TBL] [Abstract][Full Text] [Related]
14. Extreme nonfasting remnant cholesterol vs extreme LDL cholesterol as contributors to cardiovascular disease and all-cause mortality in 90000 individuals from the general population.
Varbo A; Freiberg JJ; Nordestgaard BG
Clin Chem; 2015 Mar; 61(3):533-43. PubMed ID: 25605681
[TBL] [Abstract][Full Text] [Related]
15. A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals.
Balling M; Langsted A; Afzal S; Varbo A; Davey Smith G; Nordestgaard BG
Atherosclerosis; 2019 Jul; 286():97-104. PubMed ID: 31108411
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of non-fasting and postprandial hypertriglyceridemia and remnant cholesterol.
Nordestgaard BG; Freiberg JJ
Curr Vasc Pharmacol; 2011 May; 9(3):281-6. PubMed ID: 21314630
[TBL] [Abstract][Full Text] [Related]
17. Low nonfasting triglycerides and reduced all-cause mortality: a mendelian randomization study.
Thomsen M; Varbo A; Tybjærg-Hansen A; Nordestgaard BG
Clin Chem; 2014 May; 60(5):737-46. PubMed ID: 24436475
[TBL] [Abstract][Full Text] [Related]
18. Dual elevated remnant cholesterol and C-reactive protein in myocardial infarction, atherosclerotic cardiovascular disease, and mortality.
Doi T; Langsted A; Nordestgaard BG
Atherosclerosis; 2023 Aug; 379():117141. PubMed ID: 37217436
[TBL] [Abstract][Full Text] [Related]
19. Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study.
Wadström BN; Pedersen KM; Wulff AB; Nordestgaard BG
Diabetologia; 2023 Dec; 66(12):2238-2249. PubMed ID: 37776347
[TBL] [Abstract][Full Text] [Related]
20. Unmet need for primary prevention in individuals with hypertriglyceridaemia not eligible for statin therapy according to European Society of Cardiology/European Atherosclerosis Society guidelines: a contemporary population-based study.
Madsen CM; Varbo A; Nordestgaard BG
Eur Heart J; 2018 Feb; 39(7):610-619. PubMed ID: 29182745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
